A line on a cardiology visual aid reads, 'complete protection against a second heart attack'. In the cycle meeting it sounds like the strongest thing on the page, and it is the line most likely to bring the page back.
UCPMP gets most of the attention now, and it governs conduct, how a company behaves toward doctors. The words printed on the collateral answer to more than the code. A claim has to sit inside an older set of laws as well, and those laws do not all read a claim the same way.
The Claim Itself
UCPMP already asks that information about a drug be balanced, current, and verifiable, that claims of efficacy be backed by up to date evidence, and that the word 'safe' is never used without qualification. A line promising complete protection struggles against that on its own terms. Complete protection is an absolute claim, and the code does not allow an unqualified absolute.
What the DMRA Adds
The Drugs and Magic Remedies (Objectionable Advertisements) Act of 1954 sits underneath. One part of it, on misleading advertisements, applies to any drug and bars claims that are false or that create a wrong impression. Another part, the Schedule, prohibits advertising a drug as a cure for a long list of conditions, among them heart disease, diabetes, and cancer. The law treats a communication made confidentially to a registered medical practitioner differently from one that can reach the public, which is why a product can be detailed to a doctor at all. The exposure grows the moment a claim like that can travel beyond the doctor, on a forward, on an image shared in a patient group, where the Schedule starts to bite and the cure language on the page is exactly what the Act was written to stop. Taking part in a prohibited advertisement carries a penalty that can run to imprisonment of up to six months for a first offence.
Who a Claim Can Reach
Prescription medicines are not advertised to the public the way a consumer product is. The drugs under Schedules H, H1, and X are promoted to those who can prescribe them, not to patients. A claim that is appropriate inside a visual aid meant for a cardiologist becomes a different and riskier thing the moment it can be read by the patient in the next chair.
The Honesty Test
The Advertising Standards Council of India adds its own test. Claims have to be truthful and capable of being verified, and absolute safety claims, no side effects, completely safe, are not allowed. The council's Consumer Complaints Council takes up misleading health advertisements, sometimes on its own initiative, and a competitor or a doctor can put a claim in front of it.
Substantiation, and the Cost Map
Under all of this sits one practitioner question, substantiation. Every comparative, every superlative, every number on the page needs a reference that genuinely supports it, reflecting current evidence in a balanced way. Data on file, on its own, is not the same as a claim a reader can verify. The strongest looking claims, the absolutes and the unreferenced comparatives, are usually the weakest of all when a rule is applied to them.
So a line can win the cycle meeting and still fail the rules that govern it. What reads as confident often reads, to these laws, as unsupported. The confident claim is cheap to fix on the desk, where it is a sentence to soften or a reference to add. It is expensive to fix after print, where it is a reprint across a field force. It is most expensive after a complaint, where it becomes a finding on record.
The discipline is simple to state. For every claim that carries weight, know which rule it answers to, and have the reference ready before the page leaves the brand team. A claim built that way can still be bold, because it can be defended.
Disclaimer: This is a practitioner reading of the codes for brand teams, not legal advice. The final compliance call sits with your medical and regulatory team.